Cointime

SmartCells

company

About

SmartCells develops insulin and polymer-based products for the treatment of diabetes, fertility, thyroid, and growth hormone deficiencies.

  • 1 - 10

Highlights

Total Funding Amount
$2.10M
Funding Rounds
3
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
$482.27K
Industries
Biotechnology,Diabetes,Health Care,Therapeutics
Founded date
Aug 1, 2003
Number Of Employee
1 - 10
Operating Status
Close

SmartCells, Inc. designs and develops insulin products. It offers SmartInsulin, a self regulating injectable formulation for treating diabetes. The company's polymer-based dosing technology is used for various applications, such as fertility, thyroid, and growth hormone deficiencies; treatments with poor compliance or therapeutic window issues, such as oncology; and drug-device combinations. SmartCells, Inc. was founded in 2003 and is based in Beverly, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$2.10M
SmartCells has raised a total of $2.10M in funding over 2 rounds. Their latest funding was raised on Jul 27, 2007 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 27, 2007 Grant $872.22K 1 U.S. Army Medical Research & Development Command — Detail
Jun 19, 2006 Grant $749.99K 1 National Institutes of Health — Detail
Oct 2, 2004 Grant $482.27K 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
3
2
SmartCells is funded by 2 investors. U.S. Army Medical Research & Development Command and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
U.S. Army Medical Research & Development Command Yes Grant
National Institutes of Health Yes Grant
Cointime
Content
Company